Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
about
Metrics for glycaemic control - from HbA1c to continuous glucose monitoring.The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes.Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.The Clinical Benefits and Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients-A Systematic Scoping Review.Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled TrialDay-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.Dietary intake and risk of non-severe hypoglycemia in adolescents with type 1 diabetes.Proportion of daily capillary blood glucose readings required in the target range for target glycaemic control: shift of focus from target range to proportion in range.Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.Ambulatory glucose profile analysis of the juvenile diabetes research foundation continuous glucose monitoring dataset-Applications to the pediatric diabetes population.Glucose: archetypal biomarker in diabetes diagnosis, clinical management and research.Practical Considerations on the Use of Continuous Glucose Monitoring in Pediatrics and Older Adults and Nonadjunctive Use.12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study.Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.A coordinated control strategy for insulin and glucagon delivery in type 1 diabetes.Event-Triggered Model Predictive Control For Embedded Artificial Pancreas Systems.Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy.Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes: a Consensus Report on the Igls Criteria from the IPITA/EPITA Opinion Leaders Workshop.Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.Automatic Adaptation of Basal Insulin Using Sensor-Augmented Pump Therapy.Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trialPerformance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes
P2860
Q30252932-9AB67D58-2B5A-4BA0-920A-3C68C13DBC79Q30276534-370B40BF-0E73-4D58-84E6-37C9FC9FEFC7Q33454851-EECB65EA-1338-470C-BB08-3BEDB1208C5AQ33786175-DB33C100-5AAE-4D3F-A056-8BA034EB1B0DQ36252427-B91D9116-A49D-4E4D-9444-4B0A88E06B27Q37639313-AF5AA983-1524-4920-9AC7-A2F49C286D19Q37736558-DAED3C1F-8CB5-4596-B83E-401704783724Q38377141-BAF1B8DA-24F5-45BC-8483-51160FDEF245Q38649473-AB72B31B-632A-44C6-B7AF-F6A22FB7BDE0Q38771704-3689C87B-E1DE-4494-A629-CE443C22F030Q38811243-DDA4FA55-CAB3-4CA7-9779-A683D58A0092Q39159963-BD9148EE-5FCA-4B61-80F7-AA94952F8107Q39296810-865AA5B6-B02F-415C-A60E-29FAE5EE4F2CQ42208849-9DA332BB-1603-4D6E-829D-E3FB8EC316B2Q42696179-52EDEC51-D24B-4935-8D1B-0E7BC3F84844Q45066274-EA168A7A-47EB-48E0-8378-F2A69303ED8AQ45986119-97A7E951-D64F-4C24-9E3D-9F74F5433509Q46007893-260A8DB6-48F1-404D-BAE3-EBD716952FE7Q47288459-FA5ACBDB-9C53-460C-BB99-7072DA47BF31Q47655651-1AA01865-73CD-4460-AE99-6387D271DB44Q47831910-173F7BA4-93B2-438F-826B-DE6CB107D79FQ49885969-1AC7B439-9E40-4101-AB8A-C3D8FFB251BAQ49906467-47138A19-5BA8-4508-89C4-C3C448FEB09DQ50047761-04AFD12E-622A-4173-B254-5FC598F961C8Q52586603-D990C9D9-CFB5-47A7-B4A1-F156E494C93FQ52679965-D8C18733-8682-4AAB-938E-0300C44AC42AQ53280517-D9B2A884-D64D-4C69-934A-FE93153A7C77Q55398504-B9665803-0542-4195-9D23-178B3527B1DBQ57190370-736B12C8-58B2-438E-B608-B06D6252127FQ58777180-C3280583-61D0-4AB5-87AC-B9CB78508413
P2860
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
@ast
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
@en
type
label
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
@ast
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
@en
prefLabel
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
@ast
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
@en
P2093
P2860
P50
P356
P1433
P1476
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
@en
P2093
Ahmad Haidar
Boris Kovatchev
Brian L Levy
Bruce A Buckingham
David M Maahs
David N O'Neal
Edward R Damiano
Eric Renard
Howard Zisser
P2860
P304
P356
10.2337/DC15-2716
P407
P577
2016-07-01T00:00:00Z